Recombinant Zika Virus VLP (a.a 123-819)

Target

VLP

Nature

Recombinant

Tag/Conjugate

Unconjugated

Alternative Names

Virus-like particles; E protein; prM/M

Purity

> 95% , as determined by SDS-PAGE

Format

Liquid

Concentration

Batch dependent - please inquire should you have specific requirements

Buffer

DPBS pH 7.4, 20% sucrose

Preservative

None

Storage

Store at -80°C. Avoid multiple freeze/thaw cycles.

Introduction

Zika virus is an emerging disease that is spread by Aedes mosquitoes. The virus was first isolated in Central Africa, and has since been spread to South Asia and recently to South America. Zika virus can cause mild fever, rash, myalgia, arthralgia and headaches, with one in four infected individuals being asymptomatic. Due to similar symptoms Zika virus infected individuals can easily be mis-diagnosed as a dengue infection and vice-versa. In addition, Zika virus has been implicated in causing microcephaly through transmission in utero.

Antigen Description

Recombinant Zika virus-like particles consisting of Envelope, pre-Membrane and Membrane protein produced in mammalian HEK293 cells and the target gene encoding a.a 123-819 is expressed

Keywords

Zika virus; VLP; Envelope protein; pre-Membrane protein